HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pulmonary involvement in patients with thrombotic thrombocytopenic purpura.

AbstractOBJECTIVES:
To determine the frequency of pulmonary involvement in patients with thrombotic thrombocytopenic purpura (TTP).
METHODS:
The experience of the Oklahoma TTP-HUS (hemolytic-uremic syndrome) Registry, a population-based cohort of consecutive patients without selection or referral bias, 1995-2012, was analyzed. Evidence for pulmonary involvement in patients with TTP was also documented with a systematic review of published reports.
RESULTS:
Only one of 74 Registry patients with acquired severe ADAMTS13 deficiency (activity <10%) had clinically important pulmonary involvement (transient PaO2 , 42 mm Hg; arterial O2 saturation, 78%; normal chest X-ray). No clinically important pulmonary involvement occurred in the remaining 73 patients. The systematic review identified 144 articles with search terms for TTP and pulmonary involvement; seven, published 1978-2002, had evaluable individual patient data. Five articles described single patients; only one patient was documented to have severe acquired ADAMTS13 deficiency; in none of the five patients was pulmonary involvement clearly related to TTP. Two articles were case series of seven patients each; no patients had ADAMTS13 activity measured. Each of the 14 patients had potential etiologies other than TTP for pulmonary involvement.
CONCLUSIONS:
Only one of 74 patients in the Oklahoma Registry had clinically important pulmonary involvement. A systematic review of published reports documented no clear evidence for pulmonary involvement resulting from TTP. Clinically important pulmonary involvement may be rare in patients with TTP because (i) pulmonary microvasculature may be inherently resistant to the formation of platelet thrombi and (ii) pulmonary function can be maintained in spite of multiple microvascular thrombi.
AuthorsTimothy Nokes, James N George, Sara K Vesely, Ahmed Awab
JournalEuropean journal of haematology (Eur J Haematol) Vol. 92 Issue 2 Pg. 156-63 (Feb 2014) ISSN: 1600-0609 [Electronic] England
PMID24164539 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Review, Systematic Review)
Copyright© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Chemical References
  • ADAM Proteins
  • ADAMTS13 Protein
  • ADAMTS13 protein, human
Topics
  • ADAM Proteins (deficiency, metabolism)
  • ADAMTS13 Protein
  • Adolescent
  • Adult
  • Aged
  • Child
  • Female
  • Humans
  • Incidence
  • Lung Diseases (epidemiology, etiology)
  • Male
  • Middle Aged
  • Oklahoma
  • Purpura, Thrombotic Thrombocytopenic (complications, diagnosis)
  • Registries
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: